Chugai Using Genedata's Screening Software in Tokyo Labs | GenomeWeb
NEW YORK (GenomeWeb News) — Genedata today said that Chugai Pharmaceuticals is using its Screener software to analyze high-throughput screening data.
 
Under the agreement, Genedata said its Tokyo-based staff has helped Chugai to integrate its AssayAnalyzer and Condoseo modules to review screening data and to evaluate compounds.
 
Genedata said Chugai has been using the software to help it develop drugs for cancer and for joint and bone diseases.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.